Vertex Pharmaceuticals Incorporated VRTX stock has declined 7.9% in the past three months. One major reason for the weakness was its slightly muted first-quarter 2026 results. First-quarter revenues ...

The FDA has started a priority review of Sanofi's Gaucher disease therapy venglustat, a potentially first-in-class therapy, ...

(NASDAQ: SCYX) (“SCYNEXIS”), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare diseases, today announced that it will effect a reverse stock split of ...

The global polycystic kidney disease (PKD) market is expanding rapidly due to rising prevalence, advanced treatments, and increased awareness. The growing cases of chronic kidney diseases (CKD) ...

XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX \| TSXV: XRTX \| Frankfurt: ANU), a late-stage clinical phar ...

She is a mother, competitive dance champion, kidney transplant recipient and Vanderbilt Health nurse. Culp has worked at the Vanderbilt Heart and ...

Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of ...

XORTX Therapeutics Inc ( (TSE:XRTX) ) has shared an update.

Track Nephro Care India share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit ...

A new review has illuminated a critical but often overlooked dimension of autosomal dominant polycystic kidney disease (ADPKD ...

Super-resolution ultrasound microvascular imaging, known as ultrasound localization microscopy, was a safe, reliable, and reproducible noninvasive imaging method that quantified intrarenal ...